{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:21:19Z","timestamp":1765610479414,"version":"3.41.2"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Anesthesiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>It is unclear whether patients with diabetes are more susceptible to nerve toxicity of local anesthetics or whether nerve blocks can accelerate the progression of diabetic peripheral neuropathy. Bupivacaine is one of the most widely used local anesthetics for regional anesthesia despite many pre-clinical studies demonstrating neurotoxicity. Herein, we report the long-term functional consequences of sciatic nerve block with bupivacaine and liposomal bupivacaine (Exparel\u00ae) in an animal model of diabetes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Male Sprague Dawley rats were subject to standard chow\/vehicle or high-fat diet\/low-dose streptozotocin to induce a diabetic phenotype. Animals were then subdivided into groups that received repeated sciatic nerve blocks of saline, bupivacaine, or liposomal bupivacaine. Mechanical allodynia and thermal hyperalgesia were assessed prior to and 12 weeks following nerve blocks utilizing the von Frey and Hargreaves tests, respectively. Exploratory and locomotor activity were assessed with open field testing, and nerve conduction velocity testing was conducted prior to the termination of the study at 28 weeks.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Animals in the diabetic group developed sustained hyperglycemia &amp;gt;200\u2005mg\/dl and signs of peripheral neuropathy six weeks after treatment with streptozotocin, which persisted until the end of the study. Twelve weeks after a repeated sciatic nerve block with saline, bupivacaine, or liposomal bupivacaine, results indicate significant interaction effects of the disease group (control vs. diabetic) and local anesthetic treatment. Overall, diabetic status resulted in worse sensorimotor function compared to control animals. Treatment with perineural bupivacaine resulted in worse sensorimotor functions in both control and diabetic animals. Furthermore, bupivacaine treatment in diabetic animals with pre-existing neuropathy exacerbated sensorimotor function in some measures. In contrast, liposomal bupivacaine did not appear to cause any negative effects on functional outcomes for control or diabetic animals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our data indicate that bupivacaine, and not liposomal bupivacaine, causes long-term changes in tactile allodynia, thermal hyperalgesia, locomotor behaviors, and nerve conduction velocity in control as well as a high-fat diet\/low-dose streptozotocin rodent model of diabetes. These results highlight the necessity to investigate safe peripheral nerve block strategies to preserve long-term functional independence in patients with or at risk for diabetic peripheral neuropathy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fanes.2024.1422353","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:24:34Z","timestamp":1718133874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term sensorimotor changes after a sciatic nerve block with bupivacaine and liposomal bupivacaine in a high-fat diet\/low-dose streptozotocin rodent model of diabetes"],"prefix":"10.3389","volume":"3","author":[{"given":"Susanna C.","family":"Byram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista M.","family":"Lotesto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Volyanyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob E.","family":"Exline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Sager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen M.","family":"Foecking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"year":"2021","key":"B1"},{"key":"B2","first-page":"549","article-title":"Preventing diabetes-related morbidity and mortality in the primary care setting","volume":"94","author":"Dagogo-Jack","year":"2002","journal-title":"J Natl Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1464-5491.2012.03582.x","article-title":"Nhs diabetes guideline for the perioperative management of the adult patient with diabetes","volume":"29","author":"Dhatariya","year":"2012","journal-title":"Diabet Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/bja\/aeu270","article-title":"Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in zucker diabetic fatty rats","volume":"114","author":"Lirk","year":"2015","journal-title":"Br J Anaesth"},{"key":"B5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/anae.15258","article-title":"Regional anaesthesia in patients with diabetes","volume":"76","author":"Levy","year":"2021","journal-title":"Anaesthesia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr Diab Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S2213-8587(19)30081-6","article-title":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","volume":"7","author":"Selvarajah","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/AAP.0b013e3181ae72e8","article-title":"Preliminary results of the australasian regional anaesthesia collaboration: a prospective audit of more than 7000 peripheral nerve and plexus blocks for neurologic and other complications","volume":"34","author":"Barrington","year":"2009","journal-title":"Reg Anesth Pain Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/rapm-2018-100102","article-title":"Role of regional anesthesia and analgesia in the opioid epidemic","volume":"44","author":"Lee","year":"2019","journal-title":"Reg Anesth Pain Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bpa.2020.04.015","article-title":"Perioperative glucose management: current status and future directions","volume":"34","author":"Vogt","year":"2020","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1213\/00000539-199910000-00037","article-title":"Brachial neuropathy after hemodialysis shunt placement under axillary blockade","volume":"89","author":"Hebl","year":"1999","journal-title":"Anesth Analg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.anclin.2011.04.006","article-title":"Complications of regional anesthesia and acute pain management","volume":"29","author":"Horlocker","year":"2011","journal-title":"Anesthesiol Clin"},{"key":"B13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/AAP.0b013e3181e82e0b","article-title":"Toward a potential paradigm shift for the clinical care of diabetic patients requiring perineural analgesia: strategies for using the diabetic rodent model","volume":"35","author":"Williams","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/ALN.0b013e3181829f0d","article-title":"Diabetes mellitus and subclinical neuropathy: a call for new paths in peripheral nerve block research","volume":"109","author":"Williams","year":"2008","journal-title":"Anesthesiology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/AAP.0000000000000179","article-title":"Regional anesthesia in patients with preexisting neurologic disease","volume":"40","author":"Kopp","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/AAP.0b013e3182664afb","article-title":"In zucker diabetic fatty rats, subclinical diabetic neuropathy increases in vivo lidocaine block duration but not in vitro neurotoxicity","volume":"37","author":"Lirk","year":"2012","journal-title":"Reg Anesth Pain Med"},{"volume-title":"Morgan and Mikhail\u2019s Clinical Anesthesiology","year":"2023","author":"Butterworth","key":"B17"},{"key":"B18","first-page":"406","article-title":"Quantitative histologic analysis of local anesthetic-induced injury to rat sciatic nerve","volume":"250","author":"Kalichman","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1097\/00000542-199405000-00017","article-title":"Irreversible conduction block in isolated nerve by high concentrations of local anesthetics","volume":"80","author":"Lambert","year":"1994","journal-title":"Anesthesiology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1213\/ane.0b013e31819385e1","article-title":"Cytotoxicity of local anesthetics in human neuronal cells","volume":"108","author":"Perez-Castro","year":"2009","journal-title":"Anesth Analg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1213\/00000539-200202000-00016","article-title":"The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine","volume":"94","author":"Radwan","year":"2002","journal-title":"Anesth Analg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/ACO.0b013e32830c66c2","article-title":"Continuous peripheral nerve blocks in clinical practice","volume":"21","author":"Capdevila","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/RNN-190987","article-title":"Distinct neurotoxic effects of select local anesthetics on facial nerve injury and recovery","volume":"38","author":"Byram","year":"2020","journal-title":"Restor Neurol Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/RNN-160692","article-title":"Bupivacaine increases the rate of motoneuron death following peripheral nerve injury","volume":"35","author":"Byram","year":"2017","journal-title":"Restor Neurol Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/AAP.0b013e3181e82df0","article-title":"Local anesthetic sciatic nerve block and nerve fiber damage in diabetic rats","volume":"35","author":"Kroin","year":"2010","journal-title":"Reg Anesth Pain Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/AAP.0b013e31826742fd","article-title":"Effect of acute versus continuous glycemic control on duration of local anesthetic sciatic nerve block in diabetic rats","volume":"37","author":"Kroin","year":"2012","journal-title":"Reg Anesth Pain Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/EJA.0000000000000137","article-title":"Local anaesthetics: 10 essentials","volume":"31","author":"Lirk","year":"2014","journal-title":"Eur J Anaesthesiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/bja\/aes496","article-title":"Comparison of subgluteal sciatic nerve block duration in type 2 diabetic and non-diabetic patients","volume":"110","author":"Cuvillon","year":"2013","journal-title":"Br J Anaesth"},{"key":"B29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1071100712460366","article-title":"Relationship between glycosylated hemoglobin level and sciatic nerve block performance in diabetic patients","volume":"34","author":"Sertoz","year":"2013","journal-title":"Foot Ankle Int"},{"key":"B30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12917-020-02459-4","article-title":"Neurotoxicity of bupivacaine and liposome bupivacaine after sciatic nerve block in healthy and streptozotocin-induced diabetic mice","volume":"16","author":"Markova","year":"2020","journal-title":"Bmc Vet Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1016\/j.biomaterials.2014.02.015","article-title":"Multivesicular liposomal bupivacaine at the sciatic nerve","volume":"35","author":"Mcalvin","year":"2014","journal-title":"Biomaterials"},{"key":"B32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/ACO.0000000000000506","article-title":"Regional anesthesia in diabetic peripheral neuropathy","volume":"30","author":"Ten Hoope","year":"2017","journal-title":"Curr Opin Anaesthesiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/00000542-199504000-00026","article-title":"Neurologic evaluation of the rat during sciatic nerve block with lidocaine","volume":"82","author":"Thalhammer","year":"1995","journal-title":"Anesthesiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ejp.1528","article-title":"Von frey testing revisited: provision of an online algorithm for improved accuracy of 50% thresholds","volume":"24","author":"ChristenseN","year":"2020","journal-title":"Eur J Pain"},{"key":"B36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jpain.2012.02.009","article-title":"Estimating efficacy and drug ED50\u2019s using von frey thresholds: impact of weber\u2019s law and log transformation","volume":"13","author":"Mills","year":"2012","journal-title":"J Pain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1111\/2041-210X.12584","article-title":"Boris: a free, versatile open-source event-logging software for video\/audio coding and live observations","volume":"7","author":"Friard","year":"2016","journal-title":"Methods in Ecology and Evolution"},{"key":"B39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1213\/ANE.0000000000002186","article-title":"Diphenyleneiodonium mitigates bupivacaine-induced sciatic nerve damage in a diabetic neuropathy rat model by attenuating oxidative stress","volume":"125","author":"Ji","year":"2017","journal-title":"Anesth Analg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jclinane.2009.04.009","article-title":"Femoral and sciatic nerve block with 0.25% bupivacaine for surgical management of diabetic foot syndrome: an anesthetic technique for high-risk patients with diabetic nephropathy","volume":"22","author":"Kocum","year":"2010","journal-title":"J Clin Anesth"},{"key":"B41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12640-021-00461-8","article-title":"Bupivacaine induces ros-dependent autophagic damage in drg neurons via Tug1\/mtor in a high-glucose environment","volume":"40","author":"Lai","year":"2022","journal-title":"Neurotox Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1213\/ane.0b013e318168514b","article-title":"In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity","volume":"106","author":"Lirk","year":"2008","journal-title":"Anesth Analg"},{"key":"B43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.toxlet.2019.10.020","article-title":"Inhibition of Ku70 in a high-glucose environment aggravates bupivacaine-induced dorsal root ganglion neurotoxicity","volume":"318","author":"Wang","year":"2020","journal-title":"Toxicol Lett"},{"key":"B44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.4103\/ija.ija_135_22","article-title":"Estimation of the minimum effective volume of 0.5% bupivacaine for ultrasound-guided popliteal sciatic nerve block in diabetic patients with neuropathy","volume":"66","author":"Parthasarathy","year":"2022","journal-title":"Indian J Anaesth"},{"key":"B45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","article-title":"Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening","volume":"52","author":"Srinivasan","year":"2005","journal-title":"Pharmacol Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jdi.12235","article-title":"Modeling type 2 diabetes in rats using high fat diet and streptozotocin","volume":"5","author":"Skovso","year":"2014","journal-title":"J Diabetes Investig"},{"key":"B47","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/nu12010250","article-title":"Diet-Induced rodent models of diabetic peripheral neuropathy, retinopathy and nephropathy","volume":"12","author":"Preguica","year":"2020","journal-title":"Nutrients"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1167\/iovs.13-13794","article-title":"Differences and similarities in development of corneal nerve damage and peripheral neuropathy and in diet-induced obesity and type 2 diabetic rats","volume":"55","author":"Davidson","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"307285","DOI":"10.1155\/2015\/307285","article-title":"Rat models of diet-induced obesity and high fat\/low dose streptozotocin type 2 diabetes: effect of reversal of high fat diet compared to treatment with enalapril or menhaden oil on glucose utilization and neuropathic endpoints","volume":"2015","author":"Holmes","year":"2015","journal-title":"J Diabetes Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4093\/dmj.2021.0347","article-title":"Peripheral neuropathy phenotyping in rat models of type 2 diabetes mellitus: evaluating uptake of the neurodiab guidelines and identifying future directions","volume":"46","author":"Hossain","year":"2022","journal-title":"Diabetes Metab J"},{"key":"B51","doi-asserted-by":"publisher","first-page":"15593258231185460","DOI":"10.1177\/15593258231185460","article-title":"Antioxidant potential and improvement activities of Sterculia setigera delile on insulin resistance in type 2 diabetic rats induced by high-fat diet and low dose of streptozotocin","volume":"21","author":"Tchoubou","year":"2023","journal-title":"Dose Response"},{"key":"B52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1745-7254.2005.00090.x","article-title":"Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats","volume":"26","author":"Ding","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"B53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41598-017-18896-5","article-title":"Combination of high-fat\/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications","volume":"8","author":"Barriere","year":"2018","journal-title":"Sci Rep"},{"key":"B54","first-page":"461","article-title":"Neurotoxicity of local anesthetics: animal data","volume":"18","author":"Selander","year":"1993","journal-title":"Reg Anesth"},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bja.2018.09.017","article-title":"Regional anaesthesia, diabetic neuropathy, and dexmedetomidine: a neurotoxic combination?","volume":"122","author":"Lirk","year":"2019","journal-title":"Br J Anaesth"},{"key":"B56","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/AAP.0000000000000286","article-title":"The second asra practice advisory on neurologic complications associated with regional anesthesia and pain medicine: executive summary 2015","volume":"40","author":"Neal","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/00000542-199211000-00017","article-title":"Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats","volume":"77","author":"Kalichman","year":"1992","journal-title":"Anesthesiology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bja.2018.08.022","article-title":"Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats","volume":"122","author":"Yu","year":"2019","journal-title":"Br J Anaesth"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1213\/01.ANE.0000065905.88771.0D","article-title":"Procaine and mepivacaine have less toxicity in vitro than other clinically used local anesthetics","volume":"97","author":"Kasaba","year":"2003","journal-title":"Anesth Analg"},{"key":"B60","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/AAP.0000000000000283","article-title":"Safety and side effect profile of liposome bupivacaine (exparel) in peripheral nerve blocks","volume":"40","author":"Ilfeld","year":"2015","journal-title":"Reg Anesth Pain Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"key":"B62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1744-8069-9-25","article-title":"Voluntary movements as a possible non-reflexive pain assay","volume":"9","author":"Cho","year":"2013","journal-title":"Mol Pain"}],"container-title":["Frontiers in Anesthesiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fanes.2024.1422353\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:24:40Z","timestamp":1718133880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fanes.2024.1422353\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":62,"alternative-id":["10.3389\/fanes.2024.1422353"],"URL":"https:\/\/doi.org\/10.3389\/fanes.2024.1422353","relation":{},"ISSN":["2813-480X"],"issn-type":[{"type":"electronic","value":"2813-480X"}],"subject":[],"published":{"date-parts":[[2024,6,6]]},"article-number":"1422353"}}